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Oculofaciocardiodental (OFCD) and Lenz microphthalmia syndromes form part of a spectrum of X-linked
microphthalmia disorders characterized by ocular, dental, cardiac and skeletal anomalies andmental retardation.
The two syndromes are allelic, caused by mutations in the BCL-6 corepressor gene (BCOR). To extend the series of
phenotypes associated with pathogenic mutations in BCOR, we sequenced the BCOR gene in patients with (1)
Received 25 August 2008; revised 5 February 2009; accepted 6 February 2009; published online 15 April 2009
*Correspondence: Professor LG Biesecker, National Human Genome Research Institute, NIH, 49 Convent Drive, MSC 4472, Bethesda, MD 20892-4472, USA.
Tel: þ 1 301 4022041; Fax: þ1 301 4022170; E-mail: leslieb@helix.nih.gov
27These authors contributed equally to this work.
European Journal of Human Genetics (2009) 17, 1325 – 1335
& 2009 Macmillan Publishers Limited All rights reserved 1018-4813/09 $32.00
www.nature.com/ejhg
OFCD syndrome, (2) putative X-linked (‘Lenz’) microphthalmia syndrome, (3) isolated ocular defects and (4)
laterality phenotypes. We present a new cohort of females with OFCD syndrome and null mutations in BCOR,
supporting the hypothesis that BCOR is the sole molecular cause of this syndrome. We identify for the first time
mosaic BCOR mutations in two females with OFCD syndrome and one apparently asymptomatic female. We
present a female diagnosed with isolated ocular defects and identify minor features of OFCD syndrome,
suggesting that OFCD syndrome may be mild and underdiagnosed. We have sequenced a cohort of males
diagnosed with putative X-linkedmicrophthalmia and found amutation, p.P85L, in a single case, suggesting that
BCORmutations are not a major cause of X-linked microphthalmia in males. The absence of BCORmutations in a
panel of patients with non-specific laterality defects suggests that mutations in BCOR are not a major cause of
isolated heart and laterality defects. Phenotypic analysis of OFCD and Lenz microphthalmia syndromes shows
that in addition to the standard diagnostic criteria of congenital cataract, microphthalmia and radiculomegaly,
patients should be examined for skeletal defects, particularly radioulnar synostosis, and cardiac/laterality defects.
European Journal of Human Genetics (2009) 17, 1325–1335; doi:10.1038/ejhg.2009.52; published online 15 April 2009
Keywords: BCL-6 corepressor; oculofaciocardiodental syndrome; Lenz microphthalmia syndrome; mental
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Introduction
The X-linked microphthalmia syndromes, 11 of which are
currently defined (Table 1), comprise a clinically and
molecularly diverse group of disorders, a number of which
overlap with X-linked mental retardation syndromes. Lenz
microphthalmia syndrome has been recognized for more
than 50 years and was previously assumed to be a unitary
entity. However, clinical and linkage analyses suggest
that it may be aetiologically heterogeneous, linked to
both Xq27-q281 (MCOPS1; MIM 309800) or Xp11.42,3
(MCOPS2; MIM 300166). Specifically, the MCOPS2 form of
Lenz microphthalmia syndrome has been shown to be
caused by mutation of the BCL-6 corepressor gene (BCOR);3
the genetic aetiology of MCOPS1 remains unknown. The
original report of Lenz described a family with variable
ocular manifestations, including anophthalmia, micro-
phthalmia and coloboma. There were numerous extra-
ocular anomalies including mental retardation, palatal and
dental anomalies, congenital heart defects, skeletal defects
(affecting the fingers and clavicles), unilateral renal aplasia
and cryptorchidism;4 this phenotype substantially overlaps
with other X-linked microphthalmia syndromes (Table 1).
Another X-linked microphthalmia-associated condition,
oculofaciocardiodental (OFCD) syndrome, is characterized
by ocular defects (congenital cataracts, microphthalmia),
facial anomalies (septate nasal tip, high nasal bridge,
midface hypoplasia, palatal anomalies), congenital cardiac
defects (atrial/ventricular septal defects, other complex
heart defects), dental irregularities (canine radiculomegaly,
delayed and persistent dentition, hypodontia) and skeletal
anomalies (syndactyly, hammer-type flexion deformi-
ties).5–10 All affected individuals are female, with several
incidences of mother-daughter transmission.
In 2004, a sequence variant was identified within the
BCOR gene in a single family with Lenz microphthalmia
syndrome.3 The missense mutation (c.254C4T, p.P85L)
cosegregated with the disease phenotype and was not
identified in more than 450 control chromosomes. It
represents the sole molecular cause of Lenz microphthal-
mia syndrome identified to date. In the same study, BCOR
mutations were found in all tested patients with OFCD
syndrome, suggesting the two conditions were allelic. The
mutation types included nonsense, frameshift, deletion
and splicing mutations, a finding subsequently replicated
by others. Importantly, OFCD syndrome has been shown
to encompass defects of laterality, including the heart and
other viscera, suggesting that BCOR is necessary for left–
right asymmetric development and that mutations in
BCOR may represent a source of the reported male excess
of laterality defects.11,12
This study aims to expand our understanding of the
phenotypes associated with mutations in BCOR, support-
ing the hypothesis that OFCD syndrome is solely asso-
ciated with null mutations in BCOR and to identify
additional patients with Lenz microphthalmia syndrome
who carry mutations in BCOR. We have demonstrated that
mutations in BCOR may be responsible for apparently
isolated ocular anomalies and tested the hypothesis that
BCOR mutations cause non-syndromic cardiac/laterality
defects. The continuous accumulation of patient data
allows the frequency of non-cardinal phenotypes to
be estimated and improve diagnosis and treatment of
patients.
Materials and methods
Direct sequencing of the BCOR gene
The coding exons and flanking intronic sequences of the
BCOR gene were amplified by PCR and directly sequenced
as previously reported.3
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Semi-quantitative multiplex fluorescent PCR analysis
of the BCOR gene
Deletions within the BCOR gene were detected by semi-
quantitative multiplex fluorescent PCR (QMF-PCR).13,14
All exons of the BCOR gene and three control genes (DSCRI
– chromosome 21, CFTR – chromosome 7 and Factor IX –
chromosome X) were amplified in two duplicate multiplex
reactions (primer sequences in Supplementary Table 1).
One of each primer pair was labelled with the fluorescent
phosphoramidite 6-FAM dye. Amplifications were per-
formed in 25 ml reactions using the QIAGEN Multiplex
PCR kit (Qiagen, France) with 75ng of genomic DNA and a
mix of primers (concentration range 1.3–8 mM). The
reaction started with an initial denaturation of 15min
at 951C followed by 23 cycles at 951C for 30 s/601C for
30 s/721C for 45 s with an increment of 3 s per cycle. Final
extension was at 721C for 10min. PCR products were
purified and processed as previously described.14 Two
control DNAs (male and female) were included in each
experiment. Results were analysed by superimposing
fluorescent profiles of tested patients and controls.
Fluorescent in situ hybridization analysis of the BCOR
gene
To determine the proportion of cells with a deletion in the
BCOR gene, fluorescent in situ hybridization (FISH) was
performed as previously described.15 Metaphase spreads of
peripheral leucocytes were obtained according to standard
techniques. BAC clones used in FISH experiments
were provided by The Wellcome Trust Sanger Institute
(Cambridge, UK). Clones localized on chromosome Xp11.4
(RP11-320G24, RP11-330L22 and RP11-429N5) were
directly labelled with Cy3. Chromosomes were counter-
stained with DAPI. The specific signal intensity and its
sublocalization along the chromosome axis were analysed
using a Leica fluorescence microscope equipped with the
Visilog-6 program (Noesis, Les Ulis, France).
Ethics approval
The human subject research described here was reviewed
and approved by ethics committees at St Mary’s Hospital
(Manchester, UK), the National Institutes of Health (Bethesda,
Table 1 Defined X-linked microphthalmia syndromes
Syndrome nomenclature and
alternative names MIM Descriptiona Locus Gene
MCOPS1 Lenz microphthalmia
syndrome (MAA)
309800 Micro/anophthalmia, dental anomalies, skeletal/digital
anomalies, mental retardation, facial dysmorphia
Xq27-q28
MCOPS2
Oculofaciocardiodental syndrome
(MAA2)
300166 Micro/anophthalmia, congenital cataracts,
radiculomegaly, cardiac defects, skeletal/digital
anomalies, facial dysmorphia
Xp11.4 BCOR
MCOPS4 301590 Micro/anophthalmia, ankyloblepharon, mental
retardation
Xq27-28
MCOPS7
Midas syndrome
MLS
309810 Microphthalmia, linear skin pigmentation defects Xp22.2 HCCS
MCOPCT3 302300 Microphthalmia, congenital cataract
MCOPCB1 300345 Microphthalmia, coloboma
FDH
(Focal dermal hypoplasia)
Goltz syndrome
305600 Microphthalmia, coloboma, sclerocornea, linear skin
lesions, digital anomalies, mental retardation
BRESHECK syndrome 300404 Microphthalmia, CNS anomalies, skeletal anomalies,
mental retardation, renal hypoplasia
NHS
(Nance–Horan syndrome)
302350 Microcornea, cataracts, dental anomalies Xp22.13 NHS
ND
(Norrie disease)
310600 Microphthalmia, neuroretinal degeneration, mental
retardation, sensorineural deafness
Xp11.4 NDP
Not assigned; proposed as part of
the Renpenning syndrome
spectrum
300463 Microphthalmia, coloboma, skeletal/digital anomalies,
mental retardation, facial dysmorphia
Xp11.23 PQBP1
MCOPS1, microphthalmia, syndromic 1; MAA, microphthalmia and associated anomalies; MCOPS2, microphthalmia, syndromic 2; MAA2,
microphthalmia and associated anomalies 2; MCOPS4, microphthalmia, syndromic 4; MCOPS7, microphthalmia, syndromic 7; MCOPCT3,
microphthalmia, isolated, with cataract 3; MCOPCB1, microphthalmia, isolated, with coloboma 1; BRESHECK, brain anomalies, retardation,
ectodermal dysplasia, skeletal malformations, Hirschsprung disease, ear/eye anomalies, cleft palate/cryptorchidism, and kidney dysplasia/hypoplasia;
CNS, central nervous system.
aNote the large phenotypic overlap of clinical features within this group of disorders.
Mutational spectrum of BCOR
E Hilton et al
1327
European Journal of Human Genetics
MD, USA), Baylor College of Medicine (Houston, TX, USA),
and Hoˆpital Henri Mondor (Cre´teil, France).
Results
Sequence and copy number analysis of BCOR in
patients with OFCD syndrome
From existing literature and previous work, we have
identified 33 females with OFCD syndrome.3,5 –11,16 –25 In
this study, two of these patients are described in further
clinical detail11 and mutational analysis of BCOR com-
pleted in a family (mother and daughter).25 In addition
to these four previously reported patients, we have
identified a further 31 females putatively diagnosed with
OFCD syndrome and found mutations in BCOR in all
families, bringing the cohort of patients described here
to 35 cases. A summary of the phenotypes and mutat-
ions identified in patients with OFCD syndrome is
given in Table 2. The positions of mutations in relation
to the exon sequences are shown in Figure 1. The reference
sequence used for mutation numbering is given in
Supplementary Data 1. The 31 novel patients described
here brings the total number of reported cases of
OFCD syndrome to 64. We have also sequenced three
females with features of OFCD syndrome who proved
negative for BCOR mutations; however, the phenotypes
were atypical for OFCD syndrome, with a notable
lack of radiculomegaly in the dental phenotype in all
cases.
The mutations identified here and in other studies
involve deletions of significant portions of the BCOR
coding sequence, alterations to conserved splice
acceptor sites (predicted to lead to exon skipping with
concomitant frameshifts) or small insertions/deletions
which cause frameshifts and generate premature stop
codons; it is predicted that such premature stop codons
will trigger nonsense-mediated decay of the mRNA
although the generation of C-terminally truncated
protein species is also possible. The observation that, in
all females tested to date, X-inactivation is grossly
skewed in favour of the wild-type allele (data not shown)
suggests that loss of wild-type BCOR protein confers
significant selective disadvantage, certainly in haemato-
logical lineages. Females with OFCD syndrome are there-
fore functional mosaics, with cell populations and tissues
expressing either wild-type BCOR (where lack of BCOR
function is presumed lethal) or no BCOR/truncated
BCOR (where lack of BCOR function can be supported).
Amongst the pathogenic variants are two further instances
of a previously reported c.2926C4T p.R976X nonsense
mutation.3
In this study, we report for the first time two families
with individuals mosaic for a mutation in BCOR (OFCD
XVI and OFCD XVII). In OFCD XVI, the individuals mosaic
for a BCOR mutation have the cardinal phenotype
associated with OFCD syndrome. In contrast, the mosaic
individual from OFCD XVII is asymptomatic. In both
families, offspring present with the cardinal OFCD syn-
drome phenotype and are non-mosaic for heterozygous
BCOR mutations.
OFCD XVI Individuals XVI.1 and XVI.2 are monozygotic
twin sisters, both presenting with a classical OFCD
syndrome phenotype. Individual XVI.3 (the daughter
of individual XVI.1) also presented with an overlapping
array of features. Using a quantitative fluorescent PCR
method, a deletion of at least exons 4–15 was detected
in patients XVI.1 and XVI.2. However, the decrease in PCR
product amount derived from the BCOR gene was
estimated at around 75% of control peak height, rather
than the 50% expected for a non-mosaic deletion (Figure
2a and b). This result was recapitulated for all BCOR
fragments amplified and strongly suggested somatic mo-
saicism of this deletion. By contrast, amplification was
reduced to 50% of control peak height in patient XVI.3,
suggesting non-mosaic distribution of the BCOR deletion
(Figure 2c). FISH analysis was undertaken to confirm
somatic mosaicism in individuals XVI.1 and XVI.2.
FISH analysis on metaphase chromosomes from both
patients demonstrated a deletion corresponding to
BAC clone RP11-330L22 in 52/100 metaphase preparations
for each patient, with only one signal from the
X chromosome (Figure 2g; data from patient XVI.1
not shown). Two distinct signals were detected in the
remaining 48 leucocyte preparations (Figure 2h; data
from patient XVI.1 not shown). X chromosomes were
identified using an X centromere marker and by banding
pattern (not shown). These results supported the
hypothesis that these two individuals are mosaic for the
deleted region. For patient XVI.3, 100/100 metaphase
preparations generated a single signal, confirming the
non-mosaic nature of the deletion in this patient
(Figure 2i). Two BAC clones flanking RP11-330L22, RP11-
429N5 (proximal) encompassing exons 4–15 of BCOR and
RP11-320G24 (distal) were tested in patient XVI.3.
Two specific signals were detected in each metaphase
preparation, suggesting that these regions are not deleted
in this family (the proximal RP11-429N5 probe contains
sufficient sequence outside of the BCOR gene to permit
hybridization).
OFCD XVII The proband (XVII.2), a 14–month-old girl,
presented with a classical OFCD syndrome phenotype. The
mother was asymptomatic and had a normal panoramic
dental X-ray. Quantitative fluorescent PCR detected a
reduced amount of product corresponding to exons 13 and
14, suggesting a deletion of these exons in both females.
Comparison of amounts of PCR product obtained suggested
that the mother (XVII.1) was mosaic for this deletion, with
the amount of PCR product at 75% of the control peak height
Mutational spectrum of BCOR
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(Figure 2d). Amplification from exons 8 and 9 were at the
control intensity. Amplification from proband XVII.2 was
reduced to 50% for exons 13 and 14, suggesting a non-mosaic
distribution of this deletion (Figure 2e). PCR amplification
and sequencing of a region spanning the proposed deletion
region was performed to refine the deletion to 1410bp from
intron 12–14 (Figure 2f).
Clinical features of OFCD syndrome
The cohort presented here comprises 31 new females
and four previously described females with mutations in
BCOR (35 patients). However, one female (XVII.1) is
asymptomatic, despite proving mosaic for a BCOR muta-
tion, and thus is excluded from the phenotypic evaluation,
bringing the cohort of symptomatic females to 34. A
summary of the frequency of phenotypes within the 34
symptomatic females is given in Table 3.
Ocular OFCD syndrome is associated with ocular defects
and the cardinal manifestation of congenital cataract is
present in each individual in the new cohort presented
here (34/34). In addition to congenital cataract, patients
displayed an array of eye anomalies, most frequently
microphthalmia and/or microcornea in 82% of patients
(28/34; Figure 3a and b).
Facial In our cohort, 31 patients were examined for facial
anomalies and a facial phenotype was recorded in 26
patients. The most specific facial manifestation is septate
nasal cartilage, observed in 96% (25/26) of affected patients
(Figure 3a and b), often associated with a high nasal
bridge and long and/or narrow face. Many of the patients
had palatal anomalies, including cleft palate, high-arched
palate and bifid uvula (31%; 8/26).
Cardiac Where examined, the majority of patients in the
cohort presented here have a congenital heart defect (74%;
20/27), with 85% (17/20) presenting with a septal defect,
most commonly an atrial septal defect. Further cardiac
anomalies such as pentalogy of Fallot, double-outlet-right-
ventricle, valve insufficiencies and patent ductus arteriosus
are observed, suggesting a role for BCOR in multiple cardiac
processes.
Dental In this cohort, 30 patients were examined for
dental defects. Owing to age, data corresponding only to
primary dentition were available for eight patients. Of
these, 75% (6/8) have a dental phenotype of delayed
primary dentition and/or persistent primary teeth. Two
patients have thus far unaffected primary dentition but
it is anticipated that secondary dentition will be affected.
Data regarding both primary and secondary dentition
are available for 22 patients in this cohort and all have a
variety of dental anomalies associated with OFCD syn-
drome, that is, delayed/persistent dentition with multipleT
a
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unerupted teeth, root radiculomegaly and absent/dupli-
cated/fused teeth (100%; 22/22; Figure 3c). Root radiculo-
megaly, a unique and cardinal diagnostic feature of OFCD
syndrome, is present in 91% (20/22) of patients, with
diagnosis limited in the remaining two patients by the
unavailability of a dental X-ray.
Figure 1 Location of reported mutations within the BCOR gene. Arrowheads above the diagram indicate mutations described in previous reports.
Mutations indicated below the diagram are those identified in this study (see Table 2). Arrowheads in white indicate mutations corresponding to
females with OFCD syndrome. Arrowheads in grey indicate mutations corresponding to males with Lenz microphthalmia syndrome. Arrowhead in
black indicates an in-frame deletion occurring in a female with OFCD syndrome. Deletions are indicated by solid horizontal lines.
Figure 2 Evidence for somatic mosaicism in individuals XVI.1, XVI.2 and XVII.1. (a–e) QMF-PCR fluorescent spectra obtained for fragments of the
BCOR gene and control genes, with patient peaks in red and control subject peaks in blue. Patient XVI.1 (a), patient XVI.2 (b) and patient XVII.1
(d) display diminished peak intensity to approximately 75% of the control peak intensity, suggesting mosaicism of the deleted region. Patient XVI.3
(c) and patient XVII.2 (e) display diminished peak intensity to approximately 50% of the control peak intensity, suggesting a non-mosaic deletion. (f)
Sequence chromatogram of patient XVII.2, confirming a deletion between introns 12 and 14, resulting in loss of exons 13 and 14. (g– i) FISH analysis
using BAC clone RP11-330L22, encompassing the BCOR gene, with signals indicated by white arrows. Data for patient XVI.1 are equivalent to patient
XVI.2. Patient XVI.2 (g, h) displays a single signal in approximately 50% of metaphase preparations (g) whereas the remaining preparations show two
specific signals (h), confirming that these individuals are mosaic for a deletion of the BCOR gene. For patient XVI.3 (i), a specific single signal was
observed in 100% of metaphase preparations, confirming that the deletion of the BCOR gene is non-mosaic and present in all cells.
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Skeletal A number of abnormalities of the skeleton have
been reported to be associated with OFCD syndrome and
in 29 patients examined, we observe skeletal anomalies
in 28 cases. Hammer toes are present in 54% (15/28) of
affected patients (Figure 3e) and second-third toe syndac-
tyly in 57% (16/28; Figure 3d); 93% (26/28) of patients
have at least one of these phenotypes. Radioulnar syno-
stosis is more recently recognized as a skeletal feature
of OFCD syndrome and was detected in 25% (7/28)
of affected patients of the cohort described here
(Figure 3f), with a further two patients reporting limited
supination.
Other Developmental problems have been observed in
patients with OFCD syndrome and in the cohort presented
here, 18% (6/34) of patients demonstrate a level of
mental retardation, although in most cases this is mild.
Hearing loss, both conductive and sensorineural, is
Table 3 Phenotypes associated with OFCD syndrome in
patient cohort
Feature Occurrences % Affected
Females with BCOR mutation 35
Females with OFCD syndrome phenotype 34/35
Ocular
Recorded 34/34
Affected 34/34 100
Congenital cataract 34/34 100
Microphthalmia/microcornea 28/34 82
Coloboma 1/34 3
Ptosis 3/34 9
Secondary glaucoma 4/34 12
Lens dislocation 1/34 3
Optic disc dysplasia 1/34 3
Phthisis bulbi 1/34 3
Iris synechia 2/34 6
Retinal detachment 1/34 3
Facial
Recorded 31/34
Affected 26/31 84
Septate nasal cartilage 25/26 96
High nasal bridge 11/26 42
Long narrow face 8/26 31
Palate/uvula anomalies 8/26 31
Simple ears 2/26 8
Cardiac
Recorded 27/34
Affected 20/27 74
Unresolved heart murmur 1/20 5
Septal defects 17/20 85
Patent ductus arteriosus 3/20 15
Valve incompentency 4/20 20
Pentalogy of Fallot 1/20 5
Dextrocardia 1/20 5
Double outlet right ventricle 1/20 5
Dental
Recorded 30/34
Primary dentition only 8/30
Primary and secondary dentition 22/30
Affected 22/22 100
Delayed/persistent/unerupted dentition 18/22 82
Root radiculomegaly (secondary teeth) 20/22 91
Hypodontia/duplication/fusion
(secondary teeth)
14/22 63
Skeletal
Recorded 29/34
Affected 28/29 97
Hammer toes 15/28 54
Second-third toe syndactyly 16/28 57
Radioulnar synostosis/limited supination
at wrist
9/28 32
Lordosis/scoliosis/vertebral fusion 7/28 25
Short fingers 1/28 4
Other
Mental retardation 6/34 18
Cerebral atrophy 1/34 3
ADHD 1/34 3
Hearing impairment 5/34 15
Poor feeding/vomiting/reflux 3/34 9
Asplenia 1/34 3
Vesicoureteral reflux 1/34 3
ADHD, attention deficit hyperactivity disorder.
Figure 3 OFCD syndrome. (a, b) Typical facial features of OFCD
syndrome include microphthalmia (left eye of each patient), long
narrow facies and septate nasal cartilage. (c) The dental phenotype of
OFCD syndrome includes hypodontia and tooth fusion and duplica-
tion. (d, f) Digit anomalies in OFCD syndrome include second-third
toe syndactyly (d) and hammer toes (e). (f) Radioulnar synostosis in a
patient with OFCD syndrome.
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observed in 15% (5/34) of patients. Patients with OFCD
syndrome may manifest gastrointestinal problems, possi-
bly as part of a laterality phenotype, and we report feeding
difficulties and repeated vomiting and reflux in 9% (3/34)
of the cohort presented here. A further manifestation of
defective lateral patterning, asplenia, is observed in one
patient.
Sequence analysis of BCOR in males with presumed
X-linked (‘Lenz’) microphthalmia syndrome
To date, a single family in which males are affected by
X-linked microphthalmia remain the sole patients with
‘Lenz’ microphthalmia syndrome to have been shown to
carry a BCOR mutation.3 We have sequenced the BCOR
gene in 21 males with a putative diagnosis of Lenz
microphthalmia syndrome, based on an ocular phenotype
presenting with additional features of Lenz microphthal-
mia syndrome, including mental retardation, hearing
impairment and skeletal/digital anomalies. In the majority
of cases (20/21), there was no evidence of a family history.
We identified a missense mutation in one patient with
Lenz microphthalmia syndrome, c.254C4T, predicting
p.P85L substitution at the protein level (Lenz I; Table 2).
This missense change is identical to the mutation pre-
viously described to be associated with Lenz microphthal-
mia syndrome.3 The patient presented with bilateral
microphthalmia, mild mental retardation, atrial septal
defect and a typical array of skeletal and digital abnorm-
alities. Interestingly, the patient presented with right
radioulnar synostosis, a phenotype not previously asso-
ciated with Lenz microphthalmia syndrome but strongly
linked to OFCD syndrome.
We did not find a mutation in BCOR in 20 of the male
patients, suggesting that (1) the diagnosis of Lenz micro-
phthalmia syndrome is disputed or (2) mutations in BCOR
are not the major cause of Lenz microphthalmia syndrome,
a finding replicated by others.22
Sequence analysis of BCOR in patients with
unspecified ocular developmental anomalies
To investigate the contribution of mutations in BCOR in
non-specific forms of ocular and mental retardation
syndromes, we analysed the BCOR gene in a panel of 96
patients with isolated microphthalmia, coloboma and/or
mental retardation. We identified a single mutation in
BCOR in a female patient with what had been recorded as
isolated bilateral cataract and unilateral microphthalmia
(OFCD VII.1). The proband’s mother had a similar
phenotype. The mutation was c.4303_4307delCCATG
p.P1435LfsX24. On further questioning, it was found that
the patient had numerous primary teeth removed in
teenage years and had second-third toe syndactyly, sug-
gesting that this female has a mild OFCD syndrome
phenotype.
Sequence analysis of BCOR in patients with
unspecified lateral specification defects
We have previously identified defects in lateral specifica-
tion as part of the clinical spectrum of OFCD syndrome.11
We therefore hypothesize that mutations in BCOR may
account for non-syndromic laterality defects, with heart
defects representing the most common manifestation of
defects in lateral determination. This hypothesis is
supported by the observation that in population studies,
there is a B2:1 male predominance of patients with
laterality defects not attributable to mutations in
ZIC3;12,26 further X-linked genes, such as BCOR, may
therefore be involved in human lateral specification. We
analysed the BCOR gene in a panel of 96 patients with a
variety of cardiac/laterality defects. We identified sequence
alterations in three patients: a female with situs inversus
and dextrocardia (heterozygous, c.2288G4T, p.R763L),
a female with mesocardia, VSD, partial anomalous
pulmonary venous return and intestinal malrotation
(heterozygous, c.3974A4G, p.K1325R) and a male with
transposition of great arteries, pulmonary atresia, VSD and
asplenia (hemizygous, c.3974A4G, p.K1325R). These
sequence alterations do not appear in SNP databases or
within the available EST sequences. However, these
changes were also identified in three sequences from a
panel of 171 ethnically matched unaffected controls (one
female heterozygous for c.2288G4T, p.R763L; two females
heterozygous for c.3974A4G, p.K1325R), suggesting that
they are rare polymorphisms rather than pathogenic
changes.
Discussion
In this study, we have focused on the precise clinical
features of OFCD and Lenz microphthalmia syndromes,
allelic disorders caused by mutation of the BCOR gene,
as examples of X-linked syndromic microphthalmia-
associated conditions. Given the heterogeneity amongst
X-linked microphthalmia syndromes, extension of our
knowledge of the mechanism by which BCOR mutation
is associated with OFCD and Lenz microphthalmia syn-
dromes may be pertinent to other disorders. To that end,
we searched for mutations in the BCOR gene in patients
with OFCD syndrome, presumed X-linked recessive
(‘Lenz’) microphthalmia syndrome, isolated ocular defects
and lateral specification defects.
Amongst pathogenic sequence variants that cause OFCD
syndrome and Lenz microphthalmia syndromes, the
mutations presented here confirm the sharply demarcated
genotype/phenotype correlation whereby hemizygous
males that carry a missense mutation in BCOR have Lenz
microphthalmia syndrome and heterozygous females
carrying a null allele have OFCD syndrome. The phenotype
in female patients may be variable, not only due to
differential X-inactivation effects, but also due to somatic
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mosaicism, a novel finding in three females in the cohort
presented here. To date, mutations in BCOR are the sole
molecular cause of OFCD syndrome and all mutations
identified are null alleles. It is notable that females with
putative diagnoses of OFCD syndrome in the absence of
radiculomegaly prove to be negative for mutations in
BCOR, suggesting a strong association of this cardinal
phenotype with mutations in BCOR. The mutation we
found in a female patient with apparently isolated
microphthalmia and cataract suggests that OFCD
syndrome may be under diagnosed and, at the mild end
of the spectrum, may have relatively insignificant non-
ocular features.
Three patients with OFCD syndrome with manifesta-
tions consistent with defective lateral patterning
(dextrocardia, asplenia and intestinal malrotation) have
been described.11 The clinical features of two of these
patients (II.1 and III.6), who display dextrocardia and
asplenia respectively, are described in more detail in this
report. As it has been demonstrated that BCOR is necessary
in the frog embryo to confer correct lateral organization
of heart and intestinal tract, it is hypothesized that defects
of lateral patterning, particularly of internal organs, are
a feature of OFCD syndrome. The association of cardiac
septal defects and correct laterality specification is well
documented and it is likely that the high frequency of
cardiac septal defects in OFCD syndrome is the most
common manifestation of aberrant laterality specification.
Defects of the midline are aetiologically linked with lateral
patterning and it is possible that the facial clefting and
septate nasal cartilage observed in OFCD syndrome also
result from defective lateral patterning.
Amongst the skeletal features associated with OFCD
syndrome it is of note that radioulnar synostosis, a more
recently recognized feature, was detected in 25% of the
patients with a skeletal phenotype described here. This was
also a feature of the patient with Lenz microphthalmia
syndrome with the c.254C4T, p.P85L missense mutation.
This is identical to what was previously described in Lenz
microphthalmia syndrome,3 supporting the pathogenicity
of this sequence variant and also suggesting that radioulnar
synostosis is an important marker of BCOR mutation.
The genetic causes of Lenz microphthalmia syndrome
thus remain largely undefined. Subsequent to the
first report by Lenz (1955),4 there have been a large
number of reports of X-linked recessive microphthalmia
syndrome.27–41 These reports show broad phenotypic
variability in males with multiple congenital anomalies.
However, in some cases, the absence of a proven X-linked
family history must call into question the validity of the
diagnosis. It is likely that some reported cases of ‘sporadic
Lenz microphthalmia syndrome’ are in fact misdiagnosed
and represent other forms of ‘syndromic microphthalmia’.
As a result, the exact incidence of Lenz microphthalmia
syndrome remains uncertain although the number of
families with proven X-linked inheritance is very small.
Unfortunately, a genotypic diagnosis of Lenz microphthal-
mia syndrome is currently impossible due to lack of genetic
information. Lenz microphthalmia syndrome has been
associated with at least two genetic loci, one at Xq27-q281
and the second occupied by the BCOR gene.2,3 After
exclusion of a BCOR mutation in all except one of our
male cohort, we examined other candidate genes which
might be associated with X-linked microphthalmia/mental
retardation, specifically PQBP1 (mutations in which cause
microphthalmia and mental retardation)42 and BCOR-like 1
(based on homology to BCOR and chromosomal location
at Xq26.1, in the region of the MCOPS1 locus). No
mutations were found in either gene (data not shown),
demonstrating that neither is a major cause of X-linked
microphthalmia syndromes. Combined with the low
incidence of mutations in BCOR in male microphthalmia
patients, these data suggest that the major locus for
X-linked microphthalmia/mental retardation remains
unidentified.
In summary, we have undertaken careful phenotypic
analysis of both females with OFCD syndrome and male
patients with MCOPS2. Apart from ocular defects, facial
dysmorphia, congenital heart defects and dental anoma-
lies, we find a high incidence of skeletal defects. Although
both congenital heart defects and defects of laterality
determination may be associated with OFCD, we did not
find BCOR sequence variants amongst those with unspeci-
fied lateral specification defects. Nonetheless we recom-
mend that laterality defects should be investigated, both as
cardiac manifestations and intestinal problems in patients
with OFCD syndrome. Finally, we suggest that the skeletal
phenotype of radioulnar synostosis – which we have seen
to be associated with both OFCD and Lenz microphthalmia
syndrome – as a further clinical predictor of BCOR
mutation.
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